LESLEY PLOWMAN: Open Payments
NPI 1841838869 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 18 payments from 11 companies in 2025. Trend: 2023 $883 · 2024 $1,004 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $210 |
| Gilead Sciences, Inc. | 4 | $166 |
| CVRx, Inc. | 4 | $153 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Lilly USA, LLC | 1 | $120 |
| ViiV Healthcare Company | 1 | $111 |
| COLOPLAST CORP | 1 | $102 |
| Viatris Specialty LLC | 1 | $82 |
| Novo Nordisk Inc | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Kerendia, Barostim Neo System, BREZTRI, Yeztugo, MOUNJARO, CABENUVA, Altis, YUPELRI.
Industry payments across SC — which companies pay providers there.
